Plasma microRNA-133a is a new marker for both acute myocardial infarction and underlying coronary artery stenosis | Journal of Translational Medicine | Full Text
The plasma miR-125a, miR-361 and miR-133a are promising novel biomarkers for Late-Onset Hypogonadism | Scientific Reports
Serum microRNA-1 and microRNA-133a levels reflect myocardial steatosis in uncomplicated type 2 diabetes | Scientific Reports
MicroRNAs as Potential Predictors of Postoperative AF | ECR Journal
Frontiers | Circulating MicroRNAs: Biogenesis and Clinical Significance in Acute Myocardial Infarction
Plasma microRNA-133a is a new marker for both acute myocardial infarction and underlying coronary artery stenosis | Journal of Translational Medicine | Full Text
MicroRNAs in cardiovascular disease - ScienceDirect
ORIGINAL ARTICLE Plasma MicroRNA-133a as a Potential Predictor for Coronary Artery Stenosis Severity
Frontiers | miR-133: A Suppressor of Cardiac Remodeling?
miR-223-3p and miR-24-3p as novel serum-based biomarkers for myotonic dystrophy type 1: Molecular Therapy - Methods & Clinical Development
IJMS | Free Full-Text | Challenges in Using Circulating Micro-RNAs as Biomarkers for Cardiovascular Diseases
Up-regulated miR-133a orchestrates epithelial-mesenchymal transition of airway epithelial cells | Scientific Reports
Non-canonical features of microRNAs: paradigms emerging from cardiovascular disease | Nature Reviews Cardiology
Systematic review and network analysis of microRNAs involved in cardioprotection against myocardial ischemia/reperfusion injury and infarction: Involvement of redox signalling - ScienceDirect
Increased MicroRNA-1 and MicroRNA-133a Levels in Serum of Patients With Cardiovascular Disease Indicate Myocardial Damage | Circulation: Cardiovascular Genetics
Plasma MicroRNA-133a as a Potential Biomarker for Acute Coronary Syndrome
PDF) Plasma microRNA-133a is a new marker for both acute myocardial infarction and underlying coronary artery stenosis
Increased MicroRNA-1 and MicroRNA-133a Levels in Serum of Patients With Cardiovascular Disease Indicate Myocardial Damage | Circulation: Cardiovascular Genetics
Plasma Circulating Extracellular RNAs in Left Ventricular Remodeling Post-Myocardial Infarction - eBioMedicine
Frontiers | Modes of action and diagnostic value of miRNAs in sepsis
Increased MicroRNA-1 and MicroRNA-133a Levels in Serum of Patients With Cardiovascular Disease Indicate Myocardial Damage | Circulation: Cardiovascular Genetics
ORIGINAL ARTICLE Plasma MicroRNA-133a as a Potential Predictor for Coronary Artery Stenosis Severity
ORIGINAL ARTICLE Plasma MicroRNA-133a as a Potential Predictor for Coronary Artery Stenosis Severity
Twelve-month kinetics of circulating fibrosis-linked microRNAs (miR-21, miR-29, miR-30, and miR-133a) and the relationship with extracellular matrix fibrosis in dilated cardiomyopathy
Diagnostics | Free Full-Text | MicroRNAs as Biomarkers of Systemic Changes in Response to Endurance Exercise—A Comprehensive Review
